ALLR - Allarity Therapeutics clarifies on effective reverse stock split date

2023-06-28 01:55:32 ET

• Clinical-stage pharmaceutical company, Allarity Therapeutics ( NASDAQ: ALLR ) clarifies the effective date of its contemplated reverse stock split.
• The company is clarifying that the reverse stock split will not be effected on June 27, 2023, and will continue to trade without giving effect to the proposed reverse stock split until further notice.
• The ratio would be between 1-for-15 to 1-for-50 range.
• The reverse stock split is primarily intended to increase the per share trading price and bring the company into compliance with Nasdaq’s listing requirement.

For further details see: